BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 8837547)

  • 21. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.
    Martens MG
    J Reprod Med; 2003 Jun; 48(6):425-34. PubMed ID: 12856513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical management of osteoporosis. Fracture prevention.
    Brunelli MP; Einhorn TA
    Clin Orthop Relat Res; 1998 Mar; (348):15-21. PubMed ID: 9553528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
    Col NF; Bowlby LA; McGarry K
    Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
    Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
    Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment with calcitonin in osteoporosis.
    Gennari C; Agnusdei D; Camporeale A
    Horm Metab Res; 1993 Sep; 25(9):484-5. PubMed ID: 8225202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current treatment concepts in primary osteoporosis: calcitonin].
    Ringe JD
    Schweiz Med Wochenschr; 1993 Nov; 123(47):2235-40. PubMed ID: 8272794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
    Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
    J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse Romande; 2002 Aug; 122(8):377-81. PubMed ID: 12357730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitonin therapy in osteoporosis.
    Muñoz-Torres M; Alonso G; Raya MP
    Treat Endocrinol; 2004; 3(2):117-32. PubMed ID: 15743107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporotic compression fractures of the spine; current options and considerations for treatment.
    Kim DH; Vaccaro AR
    Spine J; 2006; 6(5):479-87. PubMed ID: 16934715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitonins and osteoporosis.
    Gennari C; Agnusdei D
    Br J Clin Pract; 1994; 48(4):196-200. PubMed ID: 7917799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current and investigational approaches for reversing established osteoporosis.
    Kimmel DB; Slovik DM; Lane NE
    Rheum Dis Clin North Am; 1994 Aug; 20(3):735-58. PubMed ID: 7984787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of different "coherent"-type therapeutic plans on bone mineral density and on the incidence of vertebral fractures in advanced osteoporosis].
    Cristallini S; Pedetti M; Donatelli C; Gregorio F; Filipponi P
    Recenti Prog Med; 1993 May; 84(5):336-45. PubMed ID: 8390084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of osteoporosis.
    Eastell R; Riggs BL
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):77-88. PubMed ID: 3306525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Calcitonin in the prevention and therapy of osteoporosis].
    Ringe JD
    Ther Umsch; 1991 Feb; 48(2):91-9. PubMed ID: 2035172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacologic therapy of osteoporosis].
    Kushida K
    Nihon Rinsho; 1994 Sep; 52(9):2367-77. PubMed ID: 7967083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 2. The use of bone density measurement in the diagnosis and management of osteoporosis.
    Sturtridge W; Lentle B; Hanley DA
    CMAJ; 1996 Oct; 155(7):924-9. PubMed ID: 8837541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.